Top news of the week: 25.05.2021.
Healthcare
Column: California’s stem cell program found a disease cure, but it’s being blocked by a biotech firm
A biotech firm has halted work on a state-funded disease cure, purely for its bottom line.
CHMP backs bluebird bio’s gene therapy for rare disease ALD
CHMP backs EMA approval of bluebird bio's gene therapy for rare disease cALD, giving some relief for the biotech after a challenging few months
Opening Remarks | Supply Chain Immunity - Looking Westwards?
In previous roles, Seth has worked in waste water and waste recovery systems as a process engineer, air pollution control systems in R&D, waste water treatment and water recovery …
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant
Thermo Fisher and the University of California partnered with the development and manufacturing of cell-based therapies with the construction of its 44,000 sq. ft. manufacturing facility.
Inside Vertex 3.0: Can Reshma Kewalramani repeat one of biotech's biggest success stories 'again and again and again'?
This was not how Reshma Kewalramani imagined spending her first day as Vertex CEO. The 47-year-old nephrologist should’ve been in a spacious window office on the 14th floor of the biotech’s ...
Seoul Innovation QuickFire Challenge on Smart Surgery
Johnson & Johnson Innovation and Johnson & Johnson Medical Korea Ltd., in collaboration w
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Study uses mobile device technology to support capture of patient-reported outcomes during early and ongoing use of study treatment amongst patients with...
MorphoSys to Present Data on Tafasitamab (Monjuvi(R)) at the 2021 ASCO Annual Meeting
Tafasitamab is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody, which was approved as Monjuvi(R) (tafasitamab-cxix) in July 2020 by the U.S. Food and Drug …